Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Age and comorbidity in COVID-19 mortality: a retrospective cohort study using multivariable regression and
Nuha Al-Aghbari1,2,3, Arif Maldar4, Mubashir Angolkar5
1Community Medicine Department, Faculty of Medicine and Health Sciences, University of Science and Technology, Sana'a, Yemen. noha472@yahoo.com.
Background:
Coronavirus disease 2019 (COVID-19) has significantly increased mortality worldwide, with advanced age and comorbidity burden has been identified as a major risk factors. However, the combined effect of age and comorbidity burden on COVID-19 mortality remains unclear. This study aimed to assess the independent and interactive effects of age and comorbidity burden on in-hospital mortality from COVID-19.
Methods:
A retrospective cohort study was conducted among 642 laboratory-confirmed COVID-19 patients admitted to a tertiary care hospital in Belagavi, Karnataka, India, between October 2020 and September 2021. Bivariate analysis, multivariable logistic regression, and interaction analysis were performed to examine associations with mortality.
Results:
Patients aged ≥ 50 years had significantly higher odds of mortality compared to those aged < 50 years (AOR = 2.01, 95% CI: 1.27-3.16, p = 0.002). Dyspnea (AOR = 2.88, 95% CI: 1.85-4.48, p < 0.001) and kidney disease (AOR = 6.56, 95% CI: 2.39-18.02, p < 0.001) were significant predictors of mortality. Blood glucose (per 10 mg/dL increase; AOR = 1.03, 95% CI: 1.01-1.05, p < 0.001) and pulse rate (per bpm increase; AOR = 1.02, 95% CI: 1.01-1.03, p < 0.001) were also significantly associated with mortality. Multimorbidity was not independently associated with mortality in the main model (AOR = 1.63, 95% CI: 0.67-4.00, p = 0.278). In the interaction model, no statistically significant interaction between age and multimorbidity was observed. However, predicted probabilities suggested a higher mortality risk among older patients with multimorbidity compared to other groups.
Conclusion:
Advanced age, dyspnea, kidney disease, elevated blood glucose, and pulse rate are significant predictors of COVID-19 mortality. While multimorbidity may contribute to mortality risk, no strong evidence of interaction between age and comorbidity burden was observed. These findings highlight the importance of comprehensive risk stratification using multiple clinical factors in hospitalized COVID-19 patients.
Clinical Trial:
Not applicable.
Related Concept Videos
Bias in Epidemiological Studies
Confounding in Epidemiological Studies
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Statistical Methods for Analyzing Epidemiological Data
Causality in Epidemiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...